This study was undertaken to determine the effectiveness of the Papanicolaou (Pap) smear, colposcopically-directed biopsy (CDB), and endocervical curettage (ECC) in preconization detection of @entity15709 ( @entity15709 ) of the uterine cervix. @entity1 , whose cervical conization specimens contained @entity15709 without any associated invasive lesion at Chiang Mai University Hospital between March 1998 and March 2006, were reviewed. During the study period, fifty-one @entity1 who matched the study inclusion were identified. @entity854 was detected by Pap smears in 22 @entity1 (43.1%). Among 29 @entity1 with @entity2784 on Pap smears, 9 additional glandular abnormalities were detected on CDB and/or ECC. In @entity854 was suspected in 31 @entity1 (60.8%) preoperatively. According to the histological type of @entity15709 , @entity854 suspected from preoperative evaluation was noted in 20 @entity1 (70.4%) who had pure @entity15709 . Among @entity1 with mixed @entity15709 / @entity2784 , only 12 @entity1 (50.0%) had preoperative evaluation suggesting @entity854 . These data demonstrate that the sensitivity of combining Pap smear, CDB and/or ECC in detecting glandular lesions before conization containing @entity15709 appears to be suboptimal. Further study concerning the improvement of detecting @entity15709 before conization is warranted to select the most appropriate diagnostic conization method for such lesions.

Can XXXX be predicted before cervical conization?

@entity1 :: ('9606', 'Species') :: ['women', 'Women'] @entity15709 :: ('MESH:D065311', 'Disease') :: ['AIS', 'adenocarcinoma in situ'] @entity854 :: ('MESH:D018376', 'Disease') :: ['glandular abnormality', 'total, glandular abnormality', 'Glandular abnormality'] @entity2784 :: ('MESH:D065310', 'Disease') :: ['squamous lesions', 'HSIL']
@entity15709 :: (MESH:D065311,Disease) :: ['adenocarcinoma in situ of the uterine cervix']
